The object of the meta-analysis is to compare the efficacy and safety of levosimendan with both dobutamine and placebo in patients with refractory heart failure (ReHF). Databases, mainly Pubmed, Embase, Cochrane Library, Scopus, and Google Scholar, were searched for randomized controlled trials (RCTs) regarding ReHF treatment, including levosimendan, dobutamine, and placebo. Mean difference (MD) was generated as effect size by meta-analysis for continuous variables while odds ratios (ORs) for binary variants. All the analyses were performed with Review Manager 5.4....

Atrial fibrillation (AF) is that the commonest clinical cardiopathy and its prevalence within the u. s. is predicted to achieve 6-12 million by the year 2050 [1]. many decades past, it absolutely was believed that AF was caused by a group of random and unmethodical...

Metabolic syndrome (MetS) is linked to a higher risk of cardiovascular disease and stroke. In an urban population of volunteers and non-athletes, we looked at the factors that were associated with atherosclerosis and MetS diagnosis. The goal was to identify risk factors...

False serum creatinine estimates have been discovered as a result of interference by both endogenous and exogenous substances, which have been attributed to factors such as decreased or inhibited tubular creatinine secretion, interference with serum creatinine assays...

Although Hypoplastic Left Heart Syndrome (HLHS) is a rare condition, it is nonetheless prevalent in the Middle East and East Asia. The disease is characterised by a wide fenotype range, ranging from mild mitral and aortic stenosis to severe aortic and mitral atresia...

According to the World Health Organization, diabetes mellitus is on a “ruthless march” over the world, affecting about one out of every eleven people. According to 2014 estimates, 422 million persons globally have diabetes, but the incidence of diabetes was four times lower in 1980...